Literature DB >> 22034529

Remote specialist assessment for intravenous thrombolysis of acute ischaemic stroke by telephone.

Matthew Rudd1, Helen Rodgers, Richard Curless, Mark Sudlow, Stuart Huntley, Badanahatti Madhava, Mark Garside, Christopher I Price.   

Abstract

OBJECTIVE: To describe the process, efficacy and safety of intravenous thrombolysis for acute ischaemic stroke in an emergency department (ED) setting with remote specialist support through structured telephone consultation.
DESIGN: Retrospective case series.
SETTING: Three EDs within a single stroke service in northern England. PARTICIPANTS: Patients with acute stroke given intravenous thrombolytic therapy between 6 September 2007 and 1 October 2010. OUTCOME MEASURES: Combined death and dependency at 90 days (0-2 on the modified Rankin Scale for a good outcome vs 3-6 for a poor outcome), door-to-needle time, neurological impairment and presence of treatment related haemorrhage.
RESULTS: 192 patients received intravenous thrombolysis. 94/178 (53%) were treated after remote specialist assessment. Data available from 178 patients showed similar proportions with a good outcome after each mode of assessment (56% in person and 48% by telephone). The median door-to-needle time was 8 min faster in the group assessed in person (65 vs 73 min by telephone) but there was no difference in neurological outcome or symptomatic haemorrhage. After review in person, the stroke specialist tended to treat patients with a higher median modified Rankin Scale (1 vs 0 by telephone).
CONCLUSION: In a single stroke service the clinical outcomes of treatment with intravenous thrombolysis were similar whether assessment was performed after specialist review in person or via a telemedicine service consisting of ED staff training, telephone consultation and remote review of brain imaging by a stroke specialist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034529     DOI: 10.1136/emermed-2011-200582

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  6 in total

Review 1.  The empirical foundations of telemedicine interventions for chronic disease management.

Authors:  Rashid L Bashshur; Gary W Shannon; Brian R Smith; Dale C Alverson; Nina Antoniotti; William G Barsan; Noura Bashshur; Edward M Brown; Molly J Coye; Charles R Doarn; Stewart Ferguson; Jim Grigsby; Elizabeth A Krupinski; Joseph C Kvedar; Jonathan Linkous; Ronald C Merrell; Thomas Nesbitt; Ronald Poropatich; Karen S Rheuban; Jay H Sanders; Andrew R Watson; Ronald S Weinstein; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2014-06-26       Impact factor: 3.536

Review 2.  The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Authors:  Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens
Journal:  J Neurol       Date:  2012-08-23       Impact factor: 4.849

3.  A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial.

Authors:  Phillip A Scott; William J Meurer; Shirley M Frederiksen; John D Kalbfleisch; Zhenzhen Xu; Mary N Haan; Robert Silbergleit; Lewis B Morgenstern
Journal:  Lancet Neurol       Date:  2012-12-21       Impact factor: 44.182

Review 4.  Training interventions for improving telephone consultation skills in clinicians.

Authors:  Alberto Vaona; Yannis Pappas; Rumant S Grewal; Mubasshir Ajaz; Azeem Majeed; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2017-01-05

5.  Generalization of the Right Acute Stroke Prevention Strategies in Reducing in-Hospital Delays.

Authors:  Qiang Huang; Hai-Qing Song; Xun-Ming Ji; Wei-Yang Cheng; Juan Feng; Jian Wu; Qing-Feng Ma
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

6.  Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: A meta-analysis.

Authors:  Qiang Huang; Jing-Ze Zhang; Wen-Deng Xu; Jian Wu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.